The Patent Finder
CA

Cartana AB

First filing 2018
OverviewNotableFeesChangesPatent listSources & methods

0 patents currently held, every record listed here

8 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

This portfolio holds none of the 8 US patents in force on its record. from the record

Of the 8 now held by other companies, 6 were conveyed to 10X Genomics Inc. in the filing they arrived in, and 2 more name another party. Each row says which.

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
none
Next term end

When these terms end

Each bar runs from grant to computed term end. 2022 to 2043.
US 11,352,667 Nucleic Acid Sequencing Sep 28, 2038
US 11,597,965 RNA Templated Ligation Oct 5, 2038
US 12,227,796 RNA Templated Ligation Oct 5, 2038
US 11,555,219 Method of Detecting Target Nucleic Acid Molecules May 29, 2040
US 12,188,087 Sequential Decoding of Nucleic Acids May 29, 2040
US 12,662,699 Method of Detecting an Analyte Dec 18, 2040
US 12,270,071 Methods of Detecting an Analyte Jun 26, 2041
US 12,435,364 Probes Comprising a Split Barcode Region and Methods of Use Oct 5, 2043
202620302034203820422043
8 pending applications: term is not computable until grant.Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
None of the currently held patents qualifies as notable.

Formerly held, still cited

Notable
Cited by 148 later US patents, top 1% of utility patents granted in 2023 in our data. Protection runs to 2038.
now held by 10X Genomics, Inc.
Ends Oct 2038 · High confidence
Also notable
The most cited patent in this portfolio, cited by 224 later US patents, top 1% of utility patents granted in 2022 in our data. Protection runs to 2038.
now held by 10X Genomics, Inc.
Ends Sep 2038 · High confidence
Also notable
Cited by 14 later US patents, top 5% of utility patents granted in 2023 in our data. Protection runs to 2040.
conveyed to 10X Genomics, Inc.
Ends May 2040 · High confidence

Fee deadlines

No maintenance fee falls due on this company's record before Nov 10, 2027.

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first.
Also on record: 8 patents in force now held by others · 8 applications pending · 2 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited